University of California, Davis, researchers have developed a new, neuroplasticity-promoting drug closely related to LSD that harnesses the psychedelic’s therapeutic power with reduced hallucinogenic potential. The research highlights the new drug’s potential as a treatment option for conditions like schizophrenia, where psychedelics are not prescribed for safety reasons.

A chemist studying the cellular and molecular architecture underlying neurological diseases recently received an Incentives for Large Grant Award from the College of Letters and Science at UC Davis. The Incentives for Large Grant Awards program provides faculty with up to $80,000 in support over two years to pursue large grants of over $1 million.

A program that gets students into labs as early as their first year at UC Davis transforms lives — leading many to pursue careers in research. Accelerating Success by Providing Intensive Research Experience, or ASPIRE, has begun reaching out to a wider pool of students. “We wanted to find the students who, given this opportunity, would go the farthest relative to where they started,” says co-founder Steve Luck, Distinguished Professor of Psychology.